Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04749693Recruiting

Observational Study of the Use of DBLG1 System in Real Life

Role: lead

NCT05628532Not ApplicableCompleted

DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial

Role: lead

NCT05369871Not ApplicableCompleted

Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)

Role: lead

NCT05733962Not ApplicableUnknown

Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes

Role: lead

NCT04522882Not ApplicableCompleted

Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1

Role: lead

All 5 trials loaded